Comparing the current results to its competitors, Bio Green Med Solution Inc reported Revenue increase in the 2 quarter 2026 by 0 % year on year, while most of its competitors have experienced contraction in revenues by 0 %, achieved in the same quarter.
Bio Green Med Solution Inc 's Comment on Competition and Industry Peers
The company operates in a competitive market with three main types of competitors: local distributors supplying BOMBA-certified fire equipment and SIRIM/DOSH-certified personal protective equipment (PPE), international brands such as 3M, Dupont, and Daletec with established presence in fire safety and PPE in Malaysia, and e-commerce rivals distributing low-cost alternatives on platforms like Shopee. The company differentiates itself through certified products, reliable supply chains, and e-commerce accessibility, while facing ongoing pricing challenges.
Publicly Traded Peers of Bio Green Med Solution Inc
Verastem Inc Share Performance
+5.26%
This Year
Verastem Inc
Profile
Verastem Inc is a biopharmaceutical company that focuses on discovering and developing medicines to treat cancer by targeting the underlying biology of the disease. They employ a research-driven business model to identify novel therapeutic candidates, evaluate their potential through preclinical and clinical trials, and bring them to market with the goal of improving patient outcomes. Verastem emphasizes innovation, precision medicine, and strategic collaborations to advance their pipeline of cancer therapeutics.
Gt Biopharma Inc's business model revolves around developing innovative immunotherapies for the treatment of various cancers. The company focuses on harnessing the power of the immune system to target and eliminate cancer cells through its proprietary technology platform. Gt Biopharma Inc aims to advance its therapies through clinical trials and ultimately commercialize them for the benefit of patients worldwide.
Dar Bioscience Inc. is a biopharmaceutical company that focuses on developing and commercializing innovative products for women's health. Their business model revolves around the identification of promising product candidates, conducting clinical trials to validate their safety and efficacy, and then seeking regulatory approvals and partnerships for commercialization. By addressing unmet needs in women's health, Dar Bioscience aims to improve the quality of life for women worldwide while generating revenue through product sales and collaborations.
Atossa Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for breast conditions and oncology.
Aclaris Therapeutics Inc is a company that focuses on developing and commercializing innovative therapies to address significant unmet needs in dermatology and immunology. Their business model involves researching and developing treatments for various skin and hair conditions, obtaining regulatory approvals, and marketing these therapies to healthcare professionals and patients.
Sources:
Bio Green Med Solution Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Bio Green Med Solution Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
